Список проголосовавших за комментарий " IPO Radar: A Biotech & Biopharma IPO to Open for Trading Today; Five IPOs Expected to Price Tonight<strong>IPOs Opening Today</strong>:<br/> <ul><li><strong>AnaptysBio (ANAB):</strong> The biotech developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology priced its <strong>up-sized</strong> 5.0 million share IPO at $15, <strong>at the midpoint</strong> with the $14-$16 expected price range.</li></ul><ul><li><strong>Obseva (OBSV)</strong>: The clinical-stage biopharmaceutical company developing therapeutics for conditions that compromise a woman's reproductive health priced its 6.45 million share IPO at $15, <strong>at the midpoint</strong> of the $14-$16 expected price range.</li></ul><p><br/> <strong>Upcoming IPOs</strong>:</p><ul><li><strong>January 27: JELD-WEN (JELD)</strong> — The leading door and window manufacturer is expected to price its 25.0 million share IPO within a range of $16-$18.</li></ul><ul><li><strong>January 27: Jagged Peak Energy (JAG)</strong> — The oil & natural gas company focused on acquiring & developing unconventional assets in Southern Delaware Basin is expected to price its 38.2 million share IPO within a range of 16-$18.</li></ul><ul><li><strong>January 27: REV Group (REVG)</strong> — The designer, manufacturer, and distributor of specialty vehicles & aftermarket parts is expected to price its 12.5 million share IPO within a range of $19-$21.</li></ul><ul><li><strong>January 27: Jounce Therapeutics (JNCE)</strong> — The clinical stage immunotherapy focused on transforming treatment of cancer by enabling immune system to attack tumors is expected to price its 5.4 million share IPO within a range of $13-$15.</li></ul><ul><li><strong>January 27: Visterra (VIST)</strong> — The clinical-stage biopharma focused on designing anti-body-based therapies intended to be as effective as single-dose administration is expected to price its 3.9 million share IPO within a range of $12-$14.</li></ul>"